Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy

Orphanet Journal of Rare Diseases

Catherine Chiron³  Georges Dellatolas⁴  Olivier Dulac³  Isabelle Jambaqué¹  Dorothee Leunen²  Celia Dubouch²  Charles Bouis²  Giulia Barcia³  Mathilde Chipaux²  Nicole Chemaly³  Rima Nabbout³ 

[1] Inserm, U663, Paris F-75015, France;Department of Pediatric Neurology, Centre de Reference Epilepsies Rares, Hôpital Necker Enfants Malades APHP, Paris, France;CEA, Neurospin, Gif/Yvette 91190, France;Université Paris Descartes, Inserm U669, Maison de Solenn, Paris, France

关键词: IQ;    DQ;    SCN1A mutation;    Cognitive outcome;    Psychomotor delay;    Epileptic encephalopathy;    Dravet syndrome;   

Others  :  863425
DOI  :  10.1186/1750-1172-8-176

 received in 2013-08-02, accepted in 2013-11-09,  发布年份 2013

【 摘 要 】

Background

Dravet syndrome (DS) is currently considered as an epileptic encephalopathy, a condition in which epilepsy causes deterioration or developmental delay but preliminary data suggested that cognitive course may worsen independently from epilepsy. Our objective was to prospectively analyze the neuropsychological features in a large cohort of DS patients and its relationships with epilepsy and SCN1A mutation.

Methods

81 examinations were performed in 67 patients with typical DS (9m-24y, 15 longitudinally studied) using Brunet-Lezine (developmental/intelligence quotient [DQ/IQ] and DQ sub-scores), Achenbach, Conners, and a semi-quantitative psychomotor score (SQPS). We studied the correlation between DQ/IQ/SQPS and age, epilepsy characteristics, and whether patients presented SCN1A mutation.

Results

DQ/IQ significantly decreased with age (r = −.53, p < .001), from normal before 2y (mean 80, range 64–105) to low after 3y (mean 48, range 30–69), with hyperactivity and attention disorders hampering learning abilities especially up to 6y. However, raw (not age-adjusted) DQ sub-scores increased with age during the first decade, showing that there is no regression. We did not find any significant correlation between DQ/IQ at last evaluation and epilepsy data, i.e. first seizure (age, type, duration, fever), seizures during the course (type, fever sensitivity), status epilepticus (age of onset, number, fever), photosensitivity, and treatment, except for myoclonus and focal seizures which were associated with a lower QD/IQ after 3y. SCN1A mutated patients (n = 58) seemed to exhibit worse psychomotor course than non-mutated ones (n = 9) (severe SQPS in 26% vs 0%), although their epilepsy tended to be less severe (tonic seizures in 12% vs 44% [p = 0.04], first status epilepticus before 6 m in 26% vs 67% [p = .02], mean number of SE 2.5 vs 4.5 [p = .09]). DQ sub-scores were dissociated throughout the whole course: from onset hand-eye coordination was significantly lower than language, posture and sociability (p < .01). Dissociation seemed to be more frequent in mutated than in non-mutated patients (motor SQPS was normal for in 77% vs 44% [p = 0.017] whereas language SQPS was normal for 47% vs 100%).

Conclusions

Although psychomotor/cognitive delay declines with age, there is no regression. In addition, encephalopathy is not a pure consequence of epilepsy but SCN1A mutation seems to play an additional, direct role.

【 授权许可】

   
2013 Nabbout et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Dravet C, Bureau M, Oguni H: Severe Myoclonic Epilepsy in Infancy (Dravet Syndrome). In Epileptic Syndromes in Infancy, Childhood and Adolescence. Edited by Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolff P. London: John Libbey; 2002:75-88.
• [2]Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O: Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005, 95:71-102.
• [3]Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P: De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68:1327-1332.
• [4]Depienne C, Bouteiller D, Keren B, Cheuret E, Poirier K, Trouillard O, Benyahia B, Quelin C, Carpentier W, Julia S, Afenjar A, Gautier A, Rivier F, Meyer S, Berquin P, Helias M, Py I, Rivera S, Bahi-Buisson N, Gourfinkel-An I, Cazeneuve C, Ruberg M, Brice A, Nabbout R, Leguern E: Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009, 5:e1000381.
• [5]Nabbout R, Dulac O: Epileptic syndromes in infancy and childhood. Curr Opin Neurol 2008, 21(2):161-166.
• [6]Catarino CB, Liu JY, Liagkouras I, Gibbons VS, Labrum RW, Ellis R, Woodward C, Davis MB, Smith SJ, Cross JH, Appleton RE, Yendle SC, McMahon JM, Bellows ST, Jacques TS, Zuberi SM, Koepp MJ, Martinian L, Scheffer IE, Thom M, Sisodiya SM: Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain 2011, 134:2982-3010.
• [7]Wolff M, Casse-Perrot C, Dravet C: Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006, 47(Suppl 2):45-48.
• [8]Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM: Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain 2012, 135:2329-2336.
• [9]Riva D, Vago C, Pantaleoni C, Bulgheroni S, Mantegazza M, Franceschetti S: Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes. Am J Med Genet 2009, 149A:2339-2345.
• [10]Ragona F, Brazzo D, De Giorgi I, Morbi M, Freri E, Teutonico F, Gennaro E, Zara F, Binelli S, Veggiotti P, Granata T: Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients. Brain Dev 2010, 32:71-77.
• [11]Ragona F, Granata T, Dalla Bernardina B, Offredi F, Darra F, Battaglia D, Morbi M, Brazzo D, Cappelletti S, Chieffo D, De Giorgi I, Fontana E, Freri E, Marini C, Toraldo A, Specchio N, Veggiotti P, Vigevano F, Guerrini R, Guzzetta F, Dravet C: Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients. Epilepsia 2011, 52:386-392.
• [12]Caraballo RH, Fejerman N: Dravet syndrome: a study of 53 patients. Epilepsy Res 2006, 70(Suppl 1):231-238.
• [13]Marini C, Mei D, Temudo T, Ferrari AR, Buti D, Dravet C, Dias AI, Moreira A, Calado E, Seri S, Neville B, Narbona J, Reid E, Michelucci R, Sicca F, Cross HJ, Guerrini R: Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia 2007, 48:1678-1685.
• [14]Chieffo D, Battaglia D, Lettori D, Del Re M, Brogna C, Dravet C, Mercuri E, Guzzetta F: Neuropsychological development in children with Dravet syndrome. Epilepsy Res 2011, 95(1–2):86-93.
• [15]Guzzetta F: Cognitive and behavioral characteristics of children with Dravet syndrome: an overview. Epilepsia 2011, 52(Suppl 2):35-38.
• [16]Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, Engel J, French J, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE: Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010, 51(4):676-685.
• [17]Wechsler D: WPPSI-III: Echelle d’Intelligence de Wechsler pour la période Préscolaire et Primaire. Paris: Les Editions du Centre de Psychologie Appliquée; 2004.
• [18]Wechsler D: WISC-IV: Echelle d’Intelligence de Wechsler pour Enfants. Paris: Les Editions du Centre de Psychologie Appliquée; 2005.
• [19]Joose D: Echelle de Développement Psychomoteur de la Première enfance. Brunet-Lézine Révisé. Editions et Applications Psychologiques; 2001.
• [20]Achenbach T: Manual for the Child Behavior Checklist/4–18 and 1991 Profile. Department of Psychiatry: University of Vermont, Burlington, VT, USA; 1991.
• [21]Conners CK: Conners’ Rating Scales. New York: RevisedMulti Health Systems; 1997.
• [22]Sparrow SS, Carrey NJ, Wiggins DM, Millin RP, Hosendocus SN: Vineland Adaptive Behavior Scales. Circle Pines, Minn: American Guidance Service; 1984.
• [23]Chipaux M, Villeneuve N, Sabouraud P, Desguerre I, Boddaert N, Depienne C, Chiron C, Dulac O, Nabbout R: Unusual consequences of status epilepticus in Dravet syndrome. Seizure 2010, 19:190-194.
• [24]Tsuji M, Mazaki E, Ogiwara I, Wada T, Iai M, Okumura A, Yamashita S, Yamakawa K, Osaka H: Acute encephalopathy in a patient with Dravet syndrome. Neuropediatrics 2011, 42:78-81.
• [25]Parisi P, Spalice A, Nicita F, Papetti L, Ursitti F, Verrotti A, Iannetti P, Villa MP: “Epileptic encephalopathy” of infancy and childhood: electro-clinical pictures and recent understandings. Curr Neuropharmacol 2010, 8:409-421.
• [26]Chieffo D, Ricci D, Baranello G, Martinelli D, Veredice C, Lettori D, Battaglia D, Dravet C, Mercuri E, Guzzetta F: Early development in Dravet syndrome; visual function impairment precedes cognitive decline. Epilepsy Res 2011, 93:73-79.
• [27]Chiron C, Jambaque I, Nabbout R, Lounes R, Syrota A, Dulac O: The right brain hemisphere is dominant in human infants. Brain 1997, 120:1057-1065.
• [28]Ishino H, Higashi S, Chuta M, Ohta H: Juvenile Alzheimer’s disease with myoclonus: amyloid plaques and grumose alteration in the cerebellum. Clin Neuropathol 1984, 3:193-198.
• [29]Bhatia KP, Brown P, Gregory R, Lennox GG, Manji H, Thompson PD, Ellison DW, Marsden CD: Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 1995, 118:1087-1093.
• [30]Abbott LC, Bump M, Brandl A, De Laune S: Investigation of the role of the cerebellum in the myoclonic-like movement disorder exhibited by tottering mice. Mov Disord 2000, 15(Suppl 1):53-59.
• [31]Koh KN, Lim BC, Hwang H, Park JD, Chae JH, Kim KJ, Hwang YS, Kim SK, Wang KC, Moon HK: Cerebellum can be a possible generator of progressive myoclonus. J Child Neurol 2010, 25:728-731.
• [32]Lorincz A, Nusser Z: Cell-type-dependent molecular composition of the axon initial segment. J Neurosci 2008, 28:14329-14340.